Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data (Q30873926)

27 June 2017

1 reference

title

Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data (English)

1 reference

27 June 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

Alessandro Busca

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

Simone Cesaro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

Corrado Girmenia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

Mario Luppi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

Adriano Venditti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

Livio Pagano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

7

Giuseppe Rossi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Anna Candoni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

Anna Maria Nosari

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

publication date

2 December 2014

1 reference

27 June 2017

published in

Journal of Chemotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

1-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25466728 AND SRC:MED&resulttype=core&format=json

In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Anidulafungin in combination with amphotericin B against Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Combination Therapy of Murine Mucormycosis or Aspergillosis with Iron Chelation, Polyenes, and Echinocandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Efficacy of combination antifungal therapy with intraperitoneally administered micafungin and aerosolized liposomal amphotericin B against murine invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic zygomycosis in a patient with haematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Mucormycosis treated with posaconazole: review of 96 case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

The iron chelator deferasirox protects mice from mucormycosis through iron starvation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Differentiation of Rhizomucor species on the basis of their different sensitivities to lovastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Combination therapy for mucormycosis: why, what, and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Caspofungin for invasive fungal infections: combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Successful antifungal combination therapy with voriconazole and caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous ste

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Combination antifungal therapy and surgery for the treatment of invasive pulmonary aspergillosis after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

AcremoniumSpecies: New Emerging Fungal Opportunists—In Vitro Antifungal Susceptibilities and Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Scedosporiosis in patients with acute leukemia: a retrospective multicenter report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Disseminated infection due to Scedosporium apiospermum in a patient with acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Fatal bronchial invasion of Scopulariopsis brevicaulis in an acute monocytic leukemia patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Acremonium pyomyositis in a pediatric patient with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Successful treatment of Acremonium fungemia with voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Fatal disseminated Acremonium strictum infection in a preterm newborn: a very rare cause of neonatal septicaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Lethal double infection with Acremonium strictum and Aspergillus fumigatus during induction chemotherapy in a child with ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Fatal necrotizing stomatitis due to Trichoderma longibrachiatum in a neutropenic patient with malignant lymphoma: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224

Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179/1973947814Y.0000000224